These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3326399)

  • 21. Proteus mirabilis strains of diverse type have IgA protease activity.
    Senior BW; Albrechtsen M; Kerr MA
    J Med Microbiol; 1987 Sep; 24(2):175-80. PubMed ID: 3309325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Virulence factors in Proteus bacteria from biofilm communities of catheter-associated urinary tract infections.
    Hola V; Peroutkova T; Ruzicka F
    FEMS Immunol Med Microbiol; 2012 Jul; 65(2):343-9. PubMed ID: 22533980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New aspects of RpoE in uropathogenic Proteus mirabilis.
    Liu MC; Kuo KT; Chien HF; Tsai YL; Liaw SJ
    Infect Immun; 2015 Mar; 83(3):966-77. PubMed ID: 25547796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vero cell invasiveness of Proteus mirabilis.
    Peerbooms PG; Verweij AM; MacLaren DM
    Infect Immun; 1984 Mar; 43(3):1068-71. PubMed ID: 6365782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ability of a Proteus mirabilis strain to invade the bloodstream is independent of its proticine production/proticine sensitivity type.
    Senior BW
    J Med Microbiol; 1997 May; 46(5):407-12. PubMed ID: 9152037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of urease activity in the urinary tract pathogens Staphylococcus saprophyticus and Proteus mirabilis by dimethylsulfoxide (DMSO).
    Deutch CE
    J Appl Microbiol; 2020 May; 128(5):1514-1523. PubMed ID: 31860153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The high-affinity phosphate transporter Pst is a virulence factor for Proteus mirabilis during complicated urinary tract infection.
    Jacobsen SM; Lane MC; Harro JM; Shirtliff ME; Mobley HL
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):180-93. PubMed ID: 18194341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis of
    Armbruster CE; Mobley HLT; Pearson MM
    EcoSal Plus; 2018 Feb; 8(1):. PubMed ID: 29424333
    [No Abstract]   [Full Text] [Related]  

  • 29. Proteus mirabilis biofilms and catheter-associated urinary tract infections.
    Jacobsen SM; Shirtliff ME
    Virulence; 2011; 2(5):460-5. PubMed ID: 21921687
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Host-parasite interaction in the rat renal pelvis: a possible role for pili in the pathogenesis of pyelonephritis.
    Silverblatt FJ
    J Exp Med; 1974 Dec; 140(6):1696-711. PubMed ID: 4610081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MrpJ Directly Regulates Proteus mirabilis Virulence Factors, Including Fimbriae and Type VI Secretion, during Urinary Tract Infection.
    Debnath I; Stringer AM; Smith SN; Bae E; Mobley HLT; Wade JT; Pearson MM
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30082479
    [No Abstract]   [Full Text] [Related]  

  • 32. Quantification of Urease Activity.
    Richmond S; Yep A
    Methods Mol Biol; 2019; 2021():85-96. PubMed ID: 31309498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacterial colonization behaviour: a new virulence strategy in urinary infections?
    McLean RJ; Nickel JC
    Med Hypotheses; 1991 Nov; 36(3):269-72. PubMed ID: 1787823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Independent Transurethral Urinary Tract Inoculation in a Murine Model of Ascending Infection with Proteus mirabilis.
    Smith SN
    Methods Mol Biol; 2019; 2021():159-172. PubMed ID: 31309504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zinc uptake contributes to motility and provides a competitive advantage to Proteus mirabilis during experimental urinary tract infection.
    Nielubowicz GR; Smith SN; Mobley HL
    Infect Immun; 2010 Jun; 78(6):2823-33. PubMed ID: 20385754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. UreR, the transcriptional activator of the Proteus mirabilis urease gene cluster, is required for urease activity and virulence in experimental urinary tract infections.
    Dattelbaum JD; Lockatell CV; Johnson DE; Mobley HL
    Infect Immun; 2003 Feb; 71(2):1026-30. PubMed ID: 12540589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteus mirabilis uroepithelial cell adhesin (UCA) fimbria plays a role in the colonization of the urinary tract.
    Pellegrino R; Scavone P; Umpiérrez A; Maskell DJ; Zunino P
    Pathog Dis; 2013 Mar; 67(2):104-7. PubMed ID: 23620155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Merging mythology and morphology: the multifaceted lifestyle of Proteus mirabilis.
    Armbruster CE; Mobley HL
    Nat Rev Microbiol; 2012 Nov; 10(11):743-54. PubMed ID: 23042564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of an MR/P fimbrial mutant of Proteus mirabilis: role in virulence in a mouse model of ascending urinary tract infection.
    Bahrani FK; Massad G; Lockatell CV; Johnson DE; Russell RG; Warren JW; Mobley HL
    Infect Immun; 1994 Aug; 62(8):3363-71. PubMed ID: 7913698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptome of Proteus mirabilis in the murine urinary tract: virulence and nitrogen assimilation gene expression.
    Pearson MM; Yep A; Smith SN; Mobley HL
    Infect Immun; 2011 Jul; 79(7):2619-31. PubMed ID: 21505083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.